Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

According to Dealroom, in Q1 2025, European startups have secured $15.8B through nearly 1,600 funding rounds. From AI and fintech to clean energy and biotech, startups have attracted large amounts of ...

As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

UK-based AI-first development company Isomorphic Labs revealed that it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...

Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Chief Executive Officer Lip-Bu Tan said customers told him Intel strayed from their needs and fell behind competitors on innovation. Noah Ramos, who was fired as a head of operations, said the bank ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...